Medical News Interviews
A 20 000-person study of eicosapentaenoic acid supplements gave solid scientific support for EPA use to prevent cardiovascular events among patients with established coronary artery disease. Mitsuhiro Yokoyama of Kobe University told us more about it.
[audio:https://www.audiomedica.com/podcasting/aha2005/Mitsuhiro_Yokoyama.mp3]
Click here for all the interviews from AHA 2005
Aggressive Statins: the IDEAL Treatment 17 Nov, 2005 BNP Test: Key Diagnostic Step for Heart Failure (PEP Study) 3 Sep, 2007 Statins and ARBs: a Special Combination? 17 Nov, 2005 Eptifibatide as Effective as Abciximab in Primary PCI for Acute ST Elevation Myocardial Infarction: EVA-AMI Study 6 Nov, 2007 
COVID-19 Co-Morbidity Risks Quantified from Three Continents SurveyMay 28, 2020
Ultrahypofractionated Radiation Just As Effective for Prostate CancerMay 16, 2018
First evidence that genome editing made patients with AIDS more resistant to HIVMarch 8, 2014Anticoagulation with warfarin can be beneficial in patients with atrial fibrillation and chronic kidney disease.March 7, 2014Prostate cancer: Adult exposure to bisphenol-A linked to prostate cancer riskMarch 6, 2014
